Anti-CD1a CAR T cells to selectively target T-ALL

In this issue of Blood , Sanchez-Martinez and colleagues present a novel approach to the treatment of T-acute lymphoblastic leukemia (T-ALL) using chimeric antigen receptor (CAR) T cells redirected against CD1a 1 in in vitro and xenograft models.